PHARMACOKINETICS AND NONDIALYZABILITY OF MEXILETINE IN RENAL-FAILURE

被引：12

作者：

WANG, T

WUELLNER, D

WOOSLEY, RL

STONE, WJ

机构：

[1] VANDERBILT UNIV,DEPT MED,NASHVILLE,TN 37240

[2] VANDERBILT UNIV,DEPT PHARMACOL,NASHVILLE,TN 37240

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1985年 / 37卷 / 06期

关键词：

D O I：

10.1038/clpt.1985.105

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：649 / 653

页数：5

共 14 条

[1] ENHANCED METABOLISM OF MEXILETINE AFTER PHENYTOIN ADMINISTRATION [J].

BEGG, EJ ;

CHINWAH, PM ;

WEBB, C ;

DAY, RO ;

WADE, DN .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (02) :219-223

[2] DRUG PRESCRIBING IN RENAL-FAILURE - DOSING GUIDELINES FOR ADULTS [J].

BENNETT, WM ;

ARONOFF, GR ;

MORRISON, G ;

GOLPER, TA ;

PULLIAM, J ;

WOLFSON, M ;

SINGER, I .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1983, 3 (03) :155-193

[3]

CAMPBELL NPS, 1978, BRIT J CLIN PHARMACO, V6, P103, DOI 10.1111/j.1365-2125.1978.tb00833.x

[4] MEXILETINE - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN ARRHYTHMIAS [J].

CHEW, CYC ;

COLLETT, J ;

SINGH, BN .

DRUGS, 1979, 17 (03) :161-181

[5] MEXILETINE IN THE TREATMENT OF RESISTANT VENTRICULAR ARRHYTHMIAS - ENHANCEMENT OF EFFICACY AND REDUCTION OF DOSE-RELATED SIDE-EFFECTS BY COMBINATION WITH QUINIDINE [J].

DUFF, HJ ;

RODEN, D ;

PRIMM, RK ;

OATES, JA ;

WOOSLEY, RL .

CIRCULATION, 1983, 67 (05) :1124-1128

[6]

ELALLAF D, 1982, BRIT J CLIN PHARMACO, V14, P431

[7] PRINCIPLES OF DRUG DOSE ADJUSTMENT DURING HEMODIALYSIS [J].

GIBSON, TP .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1983, 3 (02) :111-113

[8]

HASELBARTH V, 1981, CLIN PHARMACOL THER, V29, P729

[9] CEFORANIDE KINETICS IN RENAL-INSUFFICIENCY [J].

HAWKINS, SS ;

ALFORD, RH ;

STONE, WJ ;

SMYTH, RD ;

PFEFFER, M .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (04) :468-474

[10]

HERBINGER W, 1977, ADV CLIN PHARMACOL, V16, P17

← 1 2 →